Russell Investments Group, Ltd. - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 192 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,126,035
-19.5%
181,868
-7.4%
0.00%
-20.0%
Q2 2023$2,639,479
-56.1%
196,390
-45.8%
0.01%
-58.3%
Q1 2023$6,010,529
+17.0%
362,517
+31.2%
0.01%
+9.1%
Q4 2022$5,138,918
+35.5%
276,286
-6.5%
0.01%
+37.5%
Q3 2022$3,792,000
+23.4%
295,620
-32.6%
0.01%
+33.3%
Q2 2022$3,073,000
-8.1%
438,681
+8.7%
0.01%0.0%
Q1 2022$3,344,000
+5.6%
403,615
-13.8%
0.01%
+20.0%
Q4 2021$3,167,000
+33.2%
468,222
+4.2%
0.01%
+25.0%
Q3 2021$2,378,000
-14.5%
449,136
-7.2%
0.00%
-20.0%
Q2 2021$2,782,000
-8.5%
484,139
-26.7%
0.01%0.0%
Q1 2021$3,042,000
+104.6%
660,175
+48.1%
0.01%
+66.7%
Q4 2020$1,487,000
+22.8%
445,720
+9.3%
0.00%0.0%
Q3 2020$1,211,000
-16.1%
407,643
+30.2%
0.00%0.0%
Q2 2020$1,443,000
+17.1%
313,057
-2.2%
0.00%0.0%
Q1 2020$1,232,000
+37.5%
319,985
+33.5%
0.00%
+50.0%
Q4 2019$896,000
+7366.7%
239,656
+7242.4%
0.00%
Q3 2018$12,000
-70.7%
3,264
-74.9%
0.00%
Q2 2018$41,000
+2.5%
12,987
-23.1%
0.00%
Q1 2018$40,000
-41.2%
16,8950.0%0.00%
Q4 2017$68,000
+54.5%
16,895
-4.5%
0.00%
Q3 2017$44,000
-10.2%
17,6960.0%0.00%
Q2 2017$49,00017,6960.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 589,883$590,0001.38%
Broadfin Capital, LLC 8,200,000$8,610,0000.96%
Avoro Capital Advisors LLC 1,141,149$1,198,0000.24%
CORRADO ADVISORS, LLC 190,600$200,0000.12%
Baker Brothers Advisors 5,102,153$5,357,0000.05%
KINGDON CAPITAL MANAGEMENT, L.L.C. 756,311$794,0000.04%
Point72 Asset Management, L.P. 2,272,816$2,386,0000.02%
AGRAN LIBBIE 44,000$46,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 10,000$11,0000.01%
KENNEDY CAPITAL MANAGEMENT LLC 233,171$245,0000.00%
View complete list of CATALYST PHARMACEUTICALS INC shareholders